Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension
Why the study?
Does empagliflozin reduce BP and HbA1c in patients with type 2 diabetes and hypertension?
Population
Patients with type 2 diabetes and hypertension
Comparison
Empagliflozin vs Placebo
Authors
Discussion
Loading...
Member takes
Implication
Supports empagliflozin for dual BP and HbA1c reduction in T2D with hypertension; extends prior low-certainty evidence from 19 studies.
Structured PICO
Does empagliflozin reduce BP and HbA1c in patients with type 2 diabetes and hypertension?
P
Population
Patients with type 2 diabetes and hypertension
I
Intervention
Empagliflozin
C
Comparator
Placebo
O
Outcome
Blood pressure (BP) and HbA1csurrogate
Empagliflozin provides clinically meaningful reductions in blood pressure and HbA1c in patients with comorbid type 2 diabetes and hypertension.
Cite This Study
Tikkanen et al. (2014) studied this question.